Victoria Frye1, Vijay Nandi2, Sabina Hirshfield3, Mary Ann Chiasson4,5, Leo Wilton6,7, DaShawn Usher2, Donald R Hoover8, Beryl A Koblin9. 1. Department of Community Health and Social Medicine,Department of Community Health and Social Medicine, Sophie Davis Biomedical Education Program, City University of New York School of Medicine, City University of New York, New York, NY. 2. Data Analytic Services (DAS) Laboratory, New York Blood Center, New York, NY. 3. Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY. 4. Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY. 5. Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY. 6. Department of Human Development, Binghamton University, Binghamton, NY. 7. Faculty of Humanities, University of Johannesburg, Johannesburg, South Africa. 8. Department of Statistics and Biostatistics and Institute for Health, Health Care Policy and Aging Research, Rutgers, The State University of New Jersey, Piscataway, NJ; and. 9. Independent Consultant, Metuchen, NJ.
Abstract
BACKGROUND: HIV testing is critical to HIV prevention and care. Infrequent HIV testing and late HIV diagnosis have been observed among young Black men who have sex with men and transwomen. Novel interventions to increase HIV testing rates among young Black men who have sex with men and transwomen are needed. METHODS: A randomized controlled trial among 236 young Black men and transwomen who have sex with men or transwomen evaluated the efficacy of an intervention that included completion of a brief survey and receipt of a personalized recommendation of an optimal HIV testing approach. Participants completed a computerized baseline assessment and were randomized to electronically receive either a personalized recommendation or standard HIV testing information. Follow-up surveys were conducted online at 3 and 6 months. RESULTS:Retention was 92% and 93% at 3-month and 6-month follow-up, respectively. At baseline, 41% of participants reported that they tested for HIV in the past 3 months and another 25% between 4 and 6 months ago. Intent-to-treat analyses found that participants randomized to the experimental arm (personalized recommendation) were not significantly more likely to test for HIV compared with participants in the standard HIV testing information control arm at 3 months (76% vs. 71%; P = 0.40) and 6 months (73% vs. 72%; P = 0.81), respectively. CONCLUSIONS: This study evaluated an innovative intervention to increase HIV testing by matching individuals to optimal HIV testing approaches. Participants in both arms increased past 3-month HIV testing, suggesting that providing information on options and/or raising risk awareness is sufficient to significantly increase HIV testing. TRIAL REGISTRATION: ClinicalTrial.gov NCT02834572 https://clinicaltrials.gov/ct2/show/NCT02834572.
RCT Entities:
BACKGROUND: HIV testing is critical to HIV prevention and care. Infrequent HIV testing and late HIV diagnosis have been observed among young Black men who have sex with men and transwomen. Novel interventions to increase HIV testing rates among young Black men who have sex with men and transwomen are needed. METHODS: A randomized controlled trial among 236 young Black men and transwomen who have sex with men or transwomen evaluated the efficacy of an intervention that included completion of a brief survey and receipt of a personalized recommendation of an optimal HIV testing approach. Participants completed a computerized baseline assessment and were randomized to electronically receive either a personalized recommendation or standard HIV testing information. Follow-up surveys were conducted online at 3 and 6 months. RESULTS: Retention was 92% and 93% at 3-month and 6-month follow-up, respectively. At baseline, 41% of participants reported that they tested for HIV in the past 3 months and another 25% between 4 and 6 months ago. Intent-to-treat analyses found that participants randomized to the experimental arm (personalized recommendation) were not significantly more likely to test for HIV compared with participants in the standard HIV testing information control arm at 3 months (76% vs. 71%; P = 0.40) and 6 months (73% vs. 72%; P = 0.81), respectively. CONCLUSIONS: This study evaluated an innovative intervention to increase HIV testing by matching individuals to optimal HIV testing approaches. Participants in both arms increased past 3-month HIV testing, suggesting that providing information on options and/or raising risk awareness is sufficient to significantly increase HIV testing. TRIAL REGISTRATION: ClinicalTrial.gov NCT02834572 https://clinicaltrials.gov/ct2/show/NCT02834572.
Authors: Angulique Y Outlaw; Sylvie Naar-King; Jeffrey T Parsons; Monique Green-Jones; Heather Janisse; Elizabeth Secord Journal: Am J Public Health Date: 2010-02-10 Impact factor: 9.308
Authors: Leo Wilton; Jeffrey H Herbst; Patricia Coury-Doniger; Thomas M Painter; Gary English; Maria E Alvarez; Maureen Scahill; Michael A Roberson; Basil Lucas; Wayne D Johnson; James W Carey Journal: AIDS Behav Date: 2009-03-09
Authors: Beryl Koblin; Sabina Hirshfield; Mary Ann Chiasson; Leo Wilton; DaShawn Usher; Vijay Nandi; Donald R Hoover; Victoria Frye Journal: JMIR Res Protoc Date: 2017-12-19
Authors: Zihao Li; David W Purcell; Stephanie L Sansom; Demorah Hayes; H Irene Hall Journal: MMWR Morb Mortal Wkly Rep Date: 2019-03-22 Impact factor: 17.586
Authors: Julia Budzyńska; Rafał Patryn; Ilona Kozioł; Magdalena Leśniewska; Agnieszka Kopystecka; Tomasz Skubel Journal: Int J Environ Res Public Health Date: 2022-07-30 Impact factor: 4.614
Authors: Victoria Frye; Vijay Nandi; Mark Q Paige; Jermaine McCrossin; Debbie Lucy; Marya Gwadz; Patrick S Sullivan; Donald R Hoover; Leo Wilton Journal: AIDS Behav Date: 2020-11-15